This year’s most-popular content on psoriasis include research regarding disparities and socioeconomic factors that impact psoriasis treatment and an interview on shared decision making.
The top 5 most-popular psoriasis content this year includes research into geographical differences in mortality, risk factors associated with psoriasis, and the importance of shared decision-making for better managing of this skin condition.
5. Dr Patrick Burnett on Shared Decision-Making for Moderate to Severe Psoriasis
Patrick Burnett, MD, PhD, FAAD, chief medical officer of Arcutis Biotherapeutics, discussed key clinical recommendations for patients with moderate to severe psoriasis with uncontrolled disease, stressing the importance of having a conversation with patients about their end-goal in treatment, focusing bettering their quality of life.
Burnett also discussed the importance of shared decision-making in treating patients with moderate to severe psoriasis.
4. Pulling Apart Methods of Diagnosing Axial Psoriatic Arthritis, Back Pain
Despite the high prevalence of axial disease among patients with psoriatic arthritis, disagreement on definitions caused difficulty in diagnosing axial spondylarthritis and back pain. Furthermore, the researchers of this study found notable differences when comparing psoriatic arthritis with ankylosing spondylitis in terms of intensity of back pain and mobility.
3. Study Highlights Wide Variation in Mortality of Spondyloarthritis, IBD Across the Globe
Large variations in mortality rates for spondylarthritis and inflammatory bowel disease were found geographically. These variations highlight different disparities and socioeconomic factors that may have affected mortality rates across different regions.
2. TNF Inhibitors Linked to Higher Risk of Psoriasis in Patients With IBD, RA
Researchers underscored the risk of new-onset psoriasis due to tumor necrosis factor-a (TNF) inhibitor. Patients with immune-mediated inflammatory diseases had a 2-fold risk of new-onset psoriasis, according to the study.
1. Study Finds Link Between Psoriasis, NAFLD Among US Adult Outpatients
One study found outpatients with psoriasis were at greater risk of developing nonalcoholic fatty liver disease (NAFLD) than those without the skin condition. These findings validated prior research on this subject matter, that had found psoriasis to be linked to several comorbid conditions, including cardiovascular diseases, diabetes, and NAFLD.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
ICS Use Tied to Fewer Exacerbations in Patients With Bronchiectasis and Elevated Blood Eosinophils
June 6th 2025Inhaled corticosteroid (ICS) use was common among patients with bronchiectasis and was associated with reduced exacerbations and hospitalizations in those with elevated blood eosinophil counts.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More